Search

everythinglearnresearchcommunity

for

Search:↓

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

Pro-Ile could be used in cosmetics to improve skin, hair growth, and healing.

HA-P5 effectively treats acne without causing side effects seen in other treatments.

Cerasus serrulata flower extracts have strong antibacterial and antioxidant effects and may help prevent hair loss.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

Pemigatinib may be effective for treating ZMYM2::FGFR1 fusion-positive leukemia.

Targeting FGFR-1 with antisense oligonucleotides may help treat baldness by increasing hair follicle activity.

The conclusion is that Fgf18 and Tgf-ß signaling could be targeted for hair loss treatments.

Bazhengsan reduces inflammation and tissue growth in chronic prostatitis.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

Sebaceous glands can heal and regenerate after injury using their own stem cells and help from hair follicle cells.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Blocking JAK-STAT signaling can lead to hair growth.

Topical tofacitinib may grow hair better than minoxidil by increasing VEGF and reducing inflammation.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

FGF signaling is a promising target for developing treatments for wounds, metabolic diseases, and cancer.

Anti-acne medications may work by reducing the activity of a protein involved in acne development.

Some herbs and their components might help treat hair loss by affecting various biological pathways, but more research and regulation are needed.

Some leukemia treatments can cause skin reactions similar to keratosis pilaris.

Targeting the HEDGEHOG-GLI1 pathway could help treat keloids.

Tyrosine kinase inhibitors for endocrine tumors often cause skin issues, requiring early management and treatment adjustments.

Lenvatinib and sorafenib are generally safe but need dose adjustments due to side effects.

Cucurbitacin helps mice grow hair by blocking a protein that stops hair growth.

The lentiviral array can monitor and predict gene activity during stem cell differentiation.

Oleanolic acid improved hair growth in mice by affecting hair growth pathways and reducing inflammation.

Early intervention and tailored management are crucial for skin side effects in cancer treatments.

Blocking YAP/TAZ could be a new way to treat skin cancer.

Polygenic risk scores can predict the risk and outcomes of benign prostatic hyperplasia.

Vemurafenib causes skin side effects similar to RASopathies, requiring regular skin checks and UVA protection.